Oral Recombinant Methioninase Prevents Nonalcoholic Fatty Liver Disease in Mice on a High Fat Diet

Conclusion: o-rMETase inhibited the onset of NAFLD as well as prevented obesity and the onset of diabetes on a high-fat diet, offering a possibility of a new paradigm to prevent liver cirrhosis or liver cancer via NAFLD.

Source: In Vivo - April 28, 2020 Category: Research Authors: TASHIRO, Y., HAN, Q., TAN, Y., SUGISAWA, N., YAMAMOTO, J., NISHINO, H., INUBUSHI, S., SUN, Y., LIM, H., AOKI, T., MURAKAMI, M., TAKAHASHI, Y., BOUVET, M., HOFFMAN, R. M. Tags: Experimental Studies Source Type: research